In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
about
Skin concentrations and pharmacokinetics of posaconazole after oral administration.Determination of posaconazole levels in toenails of adults with onychomycosis following oral treatment with four regimens of posaconazole for 12 or 24 weeksBritish Association of Dermatologists' guidelines for the management of onychomycosis 2014.Management of Onychomycosis in Canada in 2014.Comparison of the in vitro activities of newer triazoles and established antifungal agents against Trichophyton rubrumPharmacotherapy of onychomycosis.Posaconazole: clinical pharmacology and potential for management of fungal infections.Emerging therapeutic agents for onychomycosis.A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Dermatophyte and non dermatophyte fungi in Riyadh City, Saudi Arabia.In vitro activity of ravuconazole against 923 clinical isolates of nondermatophyte filamentous fungi.Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model.The effect of ravuconazole on the pharmacokinetics of nelfinavir in healthy male volunteers.Identification and antifungal susceptibility of fungi isolated from dermatomycoses.Posaconazole for treatment of refractory invasive fungal disease.Preanalytical conditions for broth microdilution antifungal susceptibility of Microsporum spp.In vitro susceptibility testing of dermatophytes isolated from pediatric cases in Nigeria against five antifungals.Severe Dermatophytosis and Acquired or Innate Immunodeficiency: A Review.Novel Halogenated Pyrazine-Based Chalcones as Potential Antimicrobial DrugsEfficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study
P2860
Q33826421-D0C34B4C-47A3-44CA-B3B2-A44737B99587Q35191482-0DDEA832-E63F-4143-9B33-F7CB221D8515Q35437556-3C770B05-2E61-4373-9212-9A4E68CE27A5Q35578703-34757289-ED73-48C2-BAA9-7DDD62830A31Q35746245-7B727F1F-81F7-4C7F-B50E-3B227A5E00DEQ36150713-83E7012E-A6CF-4F8D-9EE9-2A9CDB40B9B8Q36233491-74ED714C-21BE-49A7-9F00-83195A1EB100Q36943999-6D410A35-3685-44BD-A550-99C8124A75E6Q38483558-03D644BF-10FC-4876-BE80-3037D00A52F9Q38681635-F6FF1B09-13CD-47CA-B436-21DEDAB3EABDQ39199456-D1D54B83-D35A-4957-B85C-7BE94BA23ABFQ40668115-F5A85CA7-816C-4B4E-8A88-4006801C6FD2Q41074681-F14B28C0-787B-43CB-B0AB-AA0C5A86A06DQ41842788-BDD4F554-5653-4038-B5EE-F3C4C8D1892CQ42198775-1C777290-55F1-4550-9B3C-484106DE78A0Q42678650-79369AF6-7C2E-4B0F-ACB7-CA496A8BC1CCQ42712070-A6050EA1-942C-4E41-821E-9F01915A9F5CQ43708431-3969B914-7EC5-4324-BCC3-4028F76C9B37Q44657018-432FB53A-673C-4623-9194-DD0B62590320Q46890845-ED2BC924-791B-47D1-97E5-15B89B6C61BEQ49613122-C8C77155-5139-40B6-AA21-D8FA4BC716CFQ58260375-8D9DCC3A-F46F-4DCB-B8E2-16EB4AA331C4Q58697730-E9969E94-F25F-4789-A2FE-866479A35D67
P2860
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
In vitro activities of posacon ...... and non-dermatophyte species.
@en
In vitro activities of posacon ...... and non-dermatophyte species.
@nl
type
label
In vitro activities of posacon ...... and non-dermatophyte species.
@en
In vitro activities of posacon ...... and non-dermatophyte species.
@nl
prefLabel
In vitro activities of posacon ...... and non-dermatophyte species.
@en
In vitro activities of posacon ...... and non-dermatophyte species.
@nl
P1433
P1476
In vitro activities of posacon ...... and non-dermatophyte species.
@en
P2860
P304
P356
10.1080/13693780410001731583
P577
2005-03-01T00:00:00Z